# Glecaprevir + Pibrentasvir

## Maviret 100/40mg

##### 臨採

| TAH Drug Code      | [OMAV](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMAV)                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of adult chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infections.                                                          |
| Dosing             | Adults and children > or = 12 years: 3 tablets PO once daily with meals (total daily dose: glecaprevir 300 mg, pibrentasvir 120 mg) for 8-16 weeks. |
| Hepatic Impairment | Dose adjustment required                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                       |
| Contraindications  | Hypersensitivity to any component of the formulation.                                                                                               |
| Adverse Effects    | Headache, fatigue, Nausea, diarrhea                                                                                                                 |
| Pregnancy          | Unknown                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/glecaprevir-+-pibrentasvir-drug-information)                                                           |

